Clinical Scorecard: Retrospective Study on the Clinical Implications of Positive Blood Cultures in Emergency Departments: Insights from a Single-Center Investigation

At a Glance

Key Highlights

• Blood culture contaminants accounted for 22.5% of positive blood cultures, with Staphylococcus epidermidis being the most frequent contaminant (33.4%).
• Escherichia coli was the most frequent true pathogen causing bacteremia (21%).
• Advanced microbiological technologies such as MALDI-TOF MS improve discrimination between contaminants and true pathogens, especially among coagulase-negative staphylococci species.

Guideline-Based Recommendations

Diagnosis

• Use standard laboratory definitions combined with infectious disease physician review considering clinical context to distinguish contaminants from true bacteremia.
• Employ advanced diagnostic methods such as MALDI-TOF MS for precise species identification.
• Define bacteremia episodes as new positive cultures occurring ≥2 days after previous positives.

Management

• Implement blood culture diversion devices to reduce contamination rates in emergency department settings.
• Interpret positive blood cultures cautiously, especially when low-virulence skin flora are isolated from a single bottle without clinical signs of infection.

Monitoring & Follow-up

• Monitor contamination rates and pathogen identification accuracy continuously to guide diagnostic stewardship.
• Review clinical course, response to therapy, and time to positivity to aid in differentiating contaminants from true infections.

Risks

• Blood culture contamination can lead to false-positive results, unnecessary antibiotic use, and increased healthcare costs.
• Failure to accurately identify contaminants may result in misdiagnosis and inappropriate management.

Patient & Prescribing Data

Emergency department patients undergoing blood culture testing excluding pediatric patients

Accurate identification of contaminants versus true pathogens informs appropriate antimicrobial therapy and reduces unnecessary treatment.

Clinical Best Practices

• Combine laboratory criteria with expert infectious disease review for interpretation of positive blood cultures.
• Utilize blood culture diversion devices to minimize contamination.
• Incorporate rapid diagnostic technologies such as MALDI-TOF MS to improve species-level identification.
• Consider clinical context including fever, source of infection, and number of positive bottles before diagnosing bacteremia.
• Exclude pediatric samples from adult ED blood culture analyses when dedicated pediatric staff and protocols differ.

References

• Arenas et al. on specimen diversion devices reducing contamination
• Tompkins et al. on initial specimen diversion device reducing contamination and false-positive infections
• Lamy et al. review on advances in blood culture diagnostics
• Standard clinical microbiology laboratory criteria for blood culture contamination
• UMass Memorial Medical Center study data September 2019–April 2020